2om9
From Proteopedia
(New page: 200px<br /> <applet load="2om9" size="450" color="white" frame="true" align="right" spinBox="true" caption="2om9, resolution 2.80Å" /> '''Ajulemic acid, a sy...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2om9.gif|left|200px]]<br /> | + | [[Image:2om9.gif|left|200px]]<br /><applet load="2om9" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2om9" size=" | + | |
caption="2om9, resolution 2.80Å" /> | caption="2om9, resolution 2.80Å" /> | ||
'''Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma'''<br /> | '''Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma'''<br /> | ||
| Line 6: | Line 5: | ||
==Overview== | ==Overview== | ||
Ajulemic acid (AJA) is a synthetic analog of THC-11-oic acid, a metabolite, of tetrahydrocannabinol (THC), the major active ingredient of the, recreational drug marijuana derived from the plant Cannabis sativa. AJA, has potent analgesic and anti-inflammatory activity in vivo, but without, the psychotropic action of THC. However, its precise mechanism of action, remains unknown. Biochemical studies indicate that AJA binds directly and, selectively to the isotype gamma of the peroxisome proliferator-activated, receptor (PPARgamma) suggesting that this may be a pharmacologically, relevant receptor for this compound and a potential target for drug, development in the treatment of pain and inflammation. Here, we report the, crystal structure of the ligand binding domain of the gamma isotype of, human PPAR in complex with ajulemic acid, determined at 2.8-A resolution., Our results show a binding mode that is compatible with other known, partial agonists of PPAR, explaining their moderate activation of the, receptor, as well as the structural basis for isotype selectivity, as, observed previously in vitro. The structure also provides clues to the, understanding of partial agonism itself, suggesting a rational approach to, the design of molecules capable of activating the receptor at levels that, avoid undesirable side effects. | Ajulemic acid (AJA) is a synthetic analog of THC-11-oic acid, a metabolite, of tetrahydrocannabinol (THC), the major active ingredient of the, recreational drug marijuana derived from the plant Cannabis sativa. AJA, has potent analgesic and anti-inflammatory activity in vivo, but without, the psychotropic action of THC. However, its precise mechanism of action, remains unknown. Biochemical studies indicate that AJA binds directly and, selectively to the isotype gamma of the peroxisome proliferator-activated, receptor (PPARgamma) suggesting that this may be a pharmacologically, relevant receptor for this compound and a potential target for drug, development in the treatment of pain and inflammation. Here, we report the, crystal structure of the ligand binding domain of the gamma isotype of, human PPAR in complex with ajulemic acid, determined at 2.8-A resolution., Our results show a binding mode that is compatible with other known, partial agonists of PPAR, explaining their moderate activation of the, receptor, as well as the structural basis for isotype selectivity, as, observed previously in vitro. The structure also provides clues to the, understanding of partial agonism itself, suggesting a rational approach to, the design of molecules capable of activating the receptor at levels that, avoid undesirable side effects. | ||
| - | |||
| - | ==Disease== | ||
| - | Known diseases associated with this structure: Abdominal body fat distribution, modifier of OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Glioblastoma, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Insulin resistance, severe, digenic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Lipodystrophy, familial partial OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Obesity, resistance to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]], Obesity, severe OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601487 601487]] | ||
==About this Structure== | ==About this Structure== | ||
| - | 2OM9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with AJA as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 2OM9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=AJA:'>AJA</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2OM9 OCA]. |
==Reference== | ==Reference== | ||
| Line 25: | Line 21: | ||
[[Category: ppar gamma]] | [[Category: ppar gamma]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 14:22:58 2008'' |
Revision as of 12:22, 23 January 2008
|
Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma
Overview
Ajulemic acid (AJA) is a synthetic analog of THC-11-oic acid, a metabolite, of tetrahydrocannabinol (THC), the major active ingredient of the, recreational drug marijuana derived from the plant Cannabis sativa. AJA, has potent analgesic and anti-inflammatory activity in vivo, but without, the psychotropic action of THC. However, its precise mechanism of action, remains unknown. Biochemical studies indicate that AJA binds directly and, selectively to the isotype gamma of the peroxisome proliferator-activated, receptor (PPARgamma) suggesting that this may be a pharmacologically, relevant receptor for this compound and a potential target for drug, development in the treatment of pain and inflammation. Here, we report the, crystal structure of the ligand binding domain of the gamma isotype of, human PPAR in complex with ajulemic acid, determined at 2.8-A resolution., Our results show a binding mode that is compatible with other known, partial agonists of PPAR, explaining their moderate activation of the, receptor, as well as the structural basis for isotype selectivity, as, observed previously in vitro. The structure also provides clues to the, understanding of partial agonism itself, suggesting a rational approach to, the design of molecules capable of activating the receptor at levels that, avoid undesirable side effects.
About this Structure
2OM9 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma., Ambrosio AL, Dias SM, Polikarpov I, Zurier RB, Burstein SH, Garratt RC, J Biol Chem. 2007 Jun 22;282(25):18625-33. Epub 2007 Apr 26. PMID:17462987
Page seeded by OCA on Wed Jan 23 14:22:58 2008
